Therapeutic method of treating patients suffering from AIDS and AIDS- related syndromes and asymptomatic HIV-seropositive patients.

摘要

A novel therapeutical utilization of L-carnitine, acyl L- carnitines and the pharmacologically acceptable salts thereof is disclosed, for treating immune and metabolic alterations in patients suffering from AIDS and AIDS-related syndromes and in asymptomatic HIV- seropositive patients. PPThe L-carnitine amount to be administered according to this novel use is about 6-8 grams daily, via the oral route or an equivalent amount of an acyl L-carnitine or a pharmacologically acceptable salt thereof, i.e. three-four times as much the dose usually administered for the already known therapeutic uses of L- carnitine.